SAN FRANCISCO – If there was a trifecta for biotechs developing new weight-loss therapies, presentations by Vivus Inc., Orexigen Therapeutics Inc. and Arena Pharmaceuticals Inc. Wednesday at the J.P. Morgan Healthcare conference would have given you a pretty good idea of who to pick for win, place and show.